Medical Oncology

, 32:201 | Cite as

Influence of an elevated nutrition risk score (NRS) on survival in patients following gastrectomy for gastric cancer

  • J. BachmannEmail author
  • T. Müller
  • A. Schröder
  • C. Riediger
  • M. Feith
  • D. Reim
  • H. Friess
  • M. E. Martignoni
Original Paper


In the last years, the impact of weight loss in patients with malignant tumors has come more and more into the focus of clinical research, as the occurrence of weight loss is often associated with a reduced survival. Weight loss can be a hint for metastases in patients suffering from malignant tumors; furthermore, these patients are usually not able to be treated with chemotherapy. The aim of the study was to show the influence of weight loss and an elevated nutrition risk score on survival following tumor resection in patients suffering from gastric cancer. In 99 patients in whom a gastrectomy due to gastric cancer was performed, the nutrition risk score was calculated and its influence on mortality, morbidity and survival was analyzed. Of the included patients, 45 % of the patients gave a history of weight loss; they had significantly more often a NRS ≥ 3. In UICC stage 1a/b, a NRS ≥ 3 was associated with a significantly reduced survival compared to patients with a NRS < 3. In early tumor stages (UICC 1a/b), a NRS ≥ 3 was associated with a significantly reduced survival, while in progressed tumor stage, the influence of a poor NRS was not significant. This seems to show that in progressed stages in patients with gastric cancer, the influence of a reduced NRS is negligible.


Gastric cancer Weight loss Nutrition risk score Survival 



No funding with regard to the study to declare.

Conflict of interest

None of the authors has a competing interest to declare.

Ethical standard

An ethical approval for the study was not obtained, because we analyzed data, which we acquired with the clinical routine and did not acquire additional data.


  1. 1.
    Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.PubMedCrossRefGoogle Scholar
  2. 2.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.PubMedCrossRefGoogle Scholar
  3. 3.
    Bozzetti F. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer. 2009;17(3):279–84.PubMedCrossRefGoogle Scholar
  4. 4.
    Gavazzi C, Colatruglio S, Sironi A, Mazzaferro V, Miceli R. Importance of early nutritional screening in patients with gastric cancer. Br J Nutr. 2011;106:1–6.CrossRefGoogle Scholar
  5. 5.
    Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg. 2008;12(7):1193–201.PubMedCrossRefGoogle Scholar
  7. 7.
    Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer. 2009;9:255.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Davidson W, Ash S, Capra S, Bauer J. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. ClinNutr. 2004;23(2):239–47.Google Scholar
  9. 9.
    Bosaeus I, Daneryd P, Svanberg E, Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer. 2001;93(3):380–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Wigmore SJ, Falconer JS, Plester CE, Ross JA, Maingay JP, Carter DC, Fearon KC. Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients. Br J Cancer. 1995;72(1):185–8.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321–36.PubMedCrossRefGoogle Scholar
  12. 12.
    Heys SD, Ogston KN. Peri-operative nutritional support: controversies and debates. Int J Surg Investig. 2000;2(2):107–15.PubMedGoogle Scholar
  13. 13.
    Ryan AM, Healy LA, Power DG, Rowley SP, Reynolds JV. Short-term nutritional implications of total gastrectomy for malignancy, and the impact of parenteral nutritional support. Clin Nutr. 2007;26(6):718–27.PubMedCrossRefGoogle Scholar
  14. 14.
    Rogers C. Postgastrectomy nutrition. Nutr Clin Pract. 2011;26(2):126–36.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • J. Bachmann
    • 1
    Email author
  • T. Müller
    • 1
  • A. Schröder
    • 1
  • C. Riediger
    • 1
  • M. Feith
    • 1
  • D. Reim
    • 1
  • H. Friess
    • 1
  • M. E. Martignoni
    • 1
  1. 1.Department of Surgery, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany

Personalised recommendations